相似文献
1
Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.
World J Gastroenterol. 2009 Dec 28;15(48):6068-74. doi: 10.3748/wjg.15.6068.
2
Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.
Gut. 2012 May;61(5):685-94. doi: 10.1136/gutjnl-2011-300265. Epub 2011 Oct 13.
3
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Gut. 2009 Feb;58(2):196-201. doi: 10.1136/gut.2007.140806. Epub 2008 Sep 29.
4
Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
World J Gastroenterol. 2019 Jan 14;25(2):269-281. doi: 10.3748/wjg.v25.i2.269.
5
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Gastroenterology. 2009 Oct;137(4):1425-34. doi: 10.1053/j.gastro.2009.07.005. Epub 2009 Jul 28.
6
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility.
Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12928. Epub 2016 Sep 12.
7
Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
Scand J Gastroenterol. 2012 Jun;47(6):619-24. doi: 10.3109/00365521.2012.666672. Epub 2012 Apr 10.
8
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.
Gastroenterology. 2015 May;148(5):1002-1011.e4. doi: 10.1053/j.gastro.2015.01.042. Epub 2015 Feb 2.
9
[An investigation of signal transduction pathway of colonic mucosal toll-like receptor 4 in patients with diarrhea-irritable bowel syndrome].
Zhonghua Nei Ke Za Zhi. 2010 Jun;49(6):491-4.
10
Mucosal cytokine imbalance in irritable bowel syndrome.
Scand J Gastroenterol. 2008;43(12):1467-76. doi: 10.1080/00365520802276127.
引用本文的文献
1
Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders.
Int J Mol Sci. 2024 Dec 16;25(24):13465. doi: 10.3390/ijms252413465.
2
Elevated Fecal Biomarkers of Colo-Rectal Epithelial Cell Activity in Irritable Bowel Syndrome.
Neurogastroenterol Motil. 2025 Apr;37(4):e14984. doi: 10.1111/nmo.14984. Epub 2024 Dec 17.
3
Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome.
Int J Mol Sci. 2024 Mar 20;25(6):3514. doi: 10.3390/ijms25063514.
4
Metabolomic Profile of Different Dietary Patterns and Their Association with Frailty Index in Community-Dwelling Older Men and Women.
Nutrients. 2022 May 27;14(11):2237. doi: 10.3390/nu14112237.
5
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1133-1145. doi: 10.1164/rccm.202001-0180OC.
6
Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
BMC Gastroenterol. 2020 Jun 12;20(1):187. doi: 10.1186/s12876-020-01336-6.
7
Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective.
Nutrients. 2020 Jun 2;12(6):1652. doi: 10.3390/nu12061652.
8
Global Plasma Profiling for Colorectal Cancer-Associated Volatile Organic Compounds: a Proof-of-Principle Study.
J Chromatogr Sci. 2019 May 1;57(5):385-396. doi: 10.1093/chromsci/bmz011.
9
Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
Sci Rep. 2018 Jul 3;8(1):10056. doi: 10.1038/s41598-018-28477-9.
10
Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile.
Clin Med Insights Gastroenterol. 2017 Aug 31;10:1179552217728905. doi: 10.1177/1179552217728905. eCollection 2017.
本文引用的文献
1
Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.
World J Gastroenterol. 2007 Dec 7;13(45):6041-7. doi: 10.3748/wjg.v13.45.6041.
2
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
Gastroenterology. 2007 Jul;133(1):24-33. doi: 10.1053/j.gastro.2007.04.005. Epub 2007 Apr 14.
3
Intestinal permeability and irritable bowel syndrome.
Neurogastroenterol Motil. 2007 Jul;19(7):545-52. doi: 10.1111/j.1365-2982.2007.00925.x.
4
Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice.
Cell Immunol. 2007 Jan;245(1):24-31. doi: 10.1016/j.cellimm.2007.03.005. Epub 2007 Apr 27.
5
Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.
BMC Syst Biol. 2007 Feb 15;1:12. doi: 10.1186/1752-0509-1-12.
6
Immune activation in patients with irritable bowel syndrome.
Gastroenterology. 2007 Mar;132(3):913-20. doi: 10.1053/j.gastro.2007.01.046. Epub 2007 Jan 26.
7
Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.
PLoS One. 2007 Feb 14;2(2):e218. doi: 10.1371/journal.pone.0000218.
8
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease.
J Proteome Res. 2007 Feb;6(2):546-51. doi: 10.1021/pr060470d.
9
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
Gastroenterology. 2007 Jan;132(1):26-37. doi: 10.1053/j.gastro.2006.11.039.
10
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
Cancer Res. 2006 Nov 15;66(22):10795-804. doi: 10.1158/0008-5472.CAN-06-0755.
Zotero 插件